Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy

Kohei Takata, Satoshi Honda, Samuel L. Sidharta, My Ngan Duong, Daisuke Shishikura, Susan W. Kim, Jordan Andrews, Belinda A. Di Bartolo, Peter J. Psaltis, Christina A. Bursill, Matthew I. Worthley, Stephen J. Nicholls

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)
4 Downloads (Pure)


Background: Although high-density lipoprotein (HDL) has atheroprotective properties, the association of HDL functionality with coronary plaques remains unclear. Methods: We investigated the association between HDL-mediated cholesterol efflux capacity (CEC) and coronary lipid burden in 74 patients who underwent near-infrared spectroscopy (NIRS) imaging for acute coronary syndrome (ACS) or stable ischemic symptoms. We measured baseline HDL-mediated CEC, distinguishing the specific pathways, and stratified patients according to their median CEC values. Coronary lipid burden was assessed as lipid core burden index (LCBI) using NIRS at baseline (n=74) and on serial imaging (n=47). Results: Patients with baseline ATP-binding cassette transporter G1 (ABCG1)-mediated CEC > median had a greater baseline LCBI {74 [20, 128] vs. 32 [5, 66]; P=0.04} or change in LCBI {−30 [−89, 0] vs. −3 [−16, 0]; P=0.048}. In addition to a negative association between baseline LCBI and change in LCBI (standardized β=−0.31; P=0.02), multivariable analysis demonstrated a significant interaction effect between clinical presentation of coronary artery disease (CAD) and baseline ABCG1-mediated CEC on change in LCBI (P=0.003), indicating that baseline ABCG1-mediated CEC was inversely associated with change in LCBI in patients with ACS (standardized β=−0.79, P=0.003), but not in those with stable ischemic symptoms (P=0.52). Conclusions: In this study, ABCG1-mediated CEC, but not ATP-binding cassette transporter A1 and scavenger receptor B type I, was associated with regression of coronary artery lipid content, especially in patients with high-risk phenotype. Further studies are required to determine the roles of ABCG1 pathway in the development coronary plaques.

Original languageEnglish
Pages (from-to)310-318
Number of pages9
JournalCardiovascular Diagnosis and Therapy
Issue number4
Publication statusPublished - Aug 2019
Externally publishedYes


  • ATP-binding cassette transporter G1
  • Cholesterol efflux
  • Coronary artery lipid content
  • High-density lipoprotein (HDL)
  • Near-infrared spectroscopy (NIRS)


Dive into the research topics of 'Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy'. Together they form a unique fingerprint.

Cite this